Biocol-TD
(Water Soluble Powder).
A Complete Protection
COMPOSITION:
Each 100 gm contain,
Tylosin Tartarate ………….. 10 gm
Doxycycline Hcl ……………. 20 gm
Colistin Sulphate ……………. 3 gm
Bromhexine …………………. 1.0 gm
DESCRIPTION:
BIOCOL-TD GIVES COMPLETE PROTECTION AGAINST CRD AND RESPIRATORY PROBLEMS AS IT CONTAINS
TYLOSINTARTRATE
Tylosin is an antibiotic from Macrolide group. To date Tylosin Tartrate is known to be the best remedy against Mycoplasmosis. At higher dosed, it also acts against gram positive and gram-negative bacteria.
DOXYCYCLINE HCL.
Doxycycline is a member of tetracycline group. It exerts its antibacterial action by inhibiting protection synthesis of bacterial cell. It is a bacteriostatic and broad spectrum antibiotic effective against gram positive and gram-negative bacteria. Doxycycline is especially good in upper repiratory tract infections.
COLISTIN SULPHATE.
It is a member of polymyxin group of antibacterial. It acts locally in gastro intestinal tract and a very potent agent against gram-negative bacteria.
BROMHEXINE.
A potent Mucolytic expectorant, which helps, liquefy the exudate and plugs formed due to bacterial and viral infections in trachea & bronchi & effectively romove them. Hence, it helps in breathing normally and stops mortality due to asphyxia.
THE COMBINTION OF FOUR MAKES BIOCOL-TD ACOMPLETE PACKAGE FOR RESPIRATORY PROBLEMS
INDICATIONS.
Effective against gram-positive and gram negative bacterial infections including CRD, CCRD, Infectious Coryza, Colibacillosis, Staphylococcal & Streptococcal infections, Fowl Cholera, and to prevent secondary bacterial infections during viral infections like ND, IB, ILT, Avian Influenza, IBD
DOSAGE
1 gm per 2/4 liters of drinking water for 5-7 days or as directed by the veterinarian
THIS DRUG IS SAFE TO USE.
CAUTION.
Always measure the drug properly to avoid over dosage and under dosage.
STORAGE:
Store in Cool and dry place, protect from light.
Keep out of reach o Children.
Use for Veterinary doctor Advice
PACKING:
100 gms, 500gms, 1000gms
There are no reviews yet.